Home > Information > Literature Highlights

Literature Highlights

"

Highlights

Explore featured research content and product highlights from abinScience.

"

2025-12-05

November Literature Highlights | Publications Featuring abinScience Products

In November 2025, abinScience’s high-quality antibodies and recombinant proteins enabled five significant publications in leading journals including Cell Genomics (IF 9.0) and Oncogene (IF 7.3). Key breakthroughs span colorectal cancer immunotherapy through non-canonical neoantigens, circCLASP1-driven macrophage polarization in breast cancer, Paris polyphylla saponins enhancing GPX4 inhibitor efficacy, Gracillin’s protection against liver ischemia-reperfusion injury, and GC7 improving pancreatic β-cell survival during islet transplantation. From critical HLA-I immunopeptidomics reagents and SPR-validated GRB2 protein to apoptosis-regulating Bcl-2 antibodies and hypusine-specific detection tools, abinScience’s products served as cornerstone reagents driving mechanistic insights and therapeutic innovation across oncology, immunology, and regenerative medicine.
2026-08-24

July 2026 Literature Digest: Antibody and Protein Research Advances Featuring abinScience Products

This July 2026 literature roundup highlights three antibody- and protein-focused studies published in MedComm, New Biotechnology, and the International Journal of Biological Macromolecules, all supported by abinScience reagents. The first identifies 17H1, a neutralizing antibody offering 100% protection against lethal mpox virus challenge by targeting a novel epitope on the A35R protein. The second engineers biparatopic affibody molecules that block sortilin to raise progranulin levels, a promising strategy for GRN-linked frontotemporal dementia, benchmarked against the clinical-stage antibody latozinemab. The third uncovers eight previously unreported transcriptional regulators driving biofilm formation and virulence in E. coli O157:H7, validated using abinScience antibodies in Western blot analysis. Together, these studies illustrate how abinScience's antibody and protein products support cutting-edge research across infectious disease, neurodegeneration, and microbial pathogenesis.
2026-07-09

abinScience Supports Army Medical University Team in Validating the Targeting Mechanism of a Baicalein–Rapamycin Self-Assembled Nanoplatform

A research team from Army Medical University published in Materials Today Bio the construction of ABR NPs — a carrier-free nanoplatform self-assembled from baicalein and rapamycin, surface-modified with Angiopep-2 to enable LRP1-mediated BBB transcytosis. The platform achieves ~77% w/w drug loading and reduced cerebral infarct volume from 37.88% to 7.84% in an MCAO mouse model via dual ROS scavenging and microglial M1/M2 polarization modulation. The LRP1 inhibitor (HB705022) used to validate the targeting mechanism was supplied by abinScience.
2026-07-09

abinScience Helps Decode How African Swine Fever Virus I10L Dismantles Host Autophagy Defenses

African swine fever virus (ASFV) causes near-100% mortality in pigs, with no effective vaccine currently available. This article reviews a study published in Autophagy by researchers at Shandong Agricultural University, showing that the ASFV-encoded I10L protein localizes to lysosomes via its transmembrane domain and specifically binds RAB7, competitively blocking recruitment of the HOPS subunit VPS39. This disrupts assembly of the STX17-SNAP29-VAMP8 SNARE complex, inhibiting autophagosome-lysosome fusion and causing autophagosomes to accumulate without degradation, thereby promoting viral replication. Deletion of I10L significantly impaired viral replication, revealing a key molecular target in ASFV immune evasion. abinScience's Anti-ASFV I10L monoclonal antibody provided critical support for endogenous co-IP and colocalization studies.
2026-06-12

abinScience-Supported Study Reveals How PS-Externalized Erythrocyte Vesicles Drive Vascular Graft Regeneration

A team at Huazhong University of Science and Technology (Nature Communications) engineered PS-externalized erythrocyte membrane vesicles (PS-EMVs) to functionalize small-diameter vascular grafts (PEMVG). PS-EMVs activate macrophage efferocytosis via the PS–MerTK axis, suppressing inflammation and calcification. PEMVG achieved 100% patency in rabbit and beagle carotid models, outperforming commercial ePTFE. Single-cell sequencing identified MP0 macrophages as the key mediator of immune-driven vascular regeneration. abinScience provided Bavituximab-APC (YP862016) for high-sensitivity quantification of PS externalization.
2026-06-05

abinScience May 2026 Literature Digest: Stroke Nanoplatforms, African Swine Fever Autophagy Evasion & Post-Sepsis Cognitive Impairment

This digest highlights three peer-reviewed studies published in May 2026 with abinScience product support. The first demonstrates that Angiopep-2-functionalized binary nanoparticles (ABR NPs) cross the blood-brain barrier via LRP1-mediated endocytosis to simultaneously scavenge ROS and suppress neuroinflammation in acute ischemic stroke, validated using the abinScience RAP LRP1 Inhibitor (HB705022). The second reveals that ASFV I10L protein blocks autolysosome formation by disrupting RAB7-HOPS-dependent SNARE assembly — an immune evasion mechanism confirmed with the abinScience Anti-ASFV I10L Monoclonal Antibody (VK445015). The third shows that exogenous lactate attenuates post-sepsis cognitive impairment by suppressing HMGB1/RAGE signaling and upregulating neurotransmitter receptors including GluN2B, detected using the abinScience Anti-GluN2B Antibody (HC330013).
2026-03-31

abinScience Supports Zhejiang University Team: NbPro Reveals Liquid-to-Solid Phase Transition of NELF Condensates in Heat Stress Transcriptional Recovery

The Lu Huasong team at Zhejiang University published in Molecular Cell the development of NbPro, a novel nanobody-based proximity labeling technique that overcomes limitations of traditional methods. Using NbPro, they identified HSPA1A and DNAJB1 as core molecular chaperones that maintain the liquid-like dynamics and reversibility of heat stress-induced NELF condensates. Through binding to the NELFA tentacle domain and regulating phosphorylation cycles, these chaperones stabilize RNA Pol II promoter-proximal pausing, prevent aberrant escape of immature Pol II, and ensure faithful and efficient transcriptional recovery after heat stress. The study uncovers the HSF1–HSPA1A/DNAJB1–NELF axis as a key mechanism for transcriptional adaptation and quality control under stress, with abinScience providing Benzonase nuclease experimental support.
2026-03-31

FungiGuard: AI Unlocks Hidden Plant Antifungal Peptides for Sustainable Crop Protection

Discover how Shanghai Jiao Tong University's FungiGuard AI model identifies novel antifungal peptides (AFPs) from plant genomes like Arabidopsis, validates AtcAFP5's strong activity against gray mold, and paves the way for eco-friendly fungal disease control in sustainable agriculture. Supported by abinScience antibodies.
2026-03-02

January Literature Highlights | Publications Featuring abinScience Products

A new year marks a new beginning. Multiple groundbreaking achievements in antibody and protein research supported by abinScience technology have been successfully published in top journals such as Communications Biology and Nature Communications. The research focuses on key directions, including B cell development and maturation, cancer cachexia, and chronic rhinitis, covering core fields such as disease mechanism analysis and target screening. abinScience provides high-purity recombinant proteins and antibodies, which serve as critical material support for related scientific research and help achieve core breakthroughs in multiple studies. This literature expresses important research advances from frontline laboratories and introduces the relevant products provided by abinScience that support these studies.
2026-02-11

December Literature Highlights | Publications Featuring abinScience Products

In December 2025, several high-impact studies leveraging abinScience's high-purity recombinant proteins and antibodies were published in prestigious journals like PNAS and American Journal of Physiology-Cell Physiology. These include innovative engineering of antigen-presenting vesicles (APVs) for selective T cell stimulation in cell-free immunotherapy, and the use of GC7 to enhance pancreatic beta cell tolerance to ischemia/reperfusion injury, potentially improving islet transplantation outcomes for diabetes. abinScience products played crucial roles in validating key mechanisms, highlighting their value in advancing immunology and metabolic disease research.
2026-02-11

Targeting SAA: A Novel Immunotherapy Strategy to Reshape the Lung Cancer Immune Microenvironment

A recent study published in Frontiers in Immunology reveals how tumor-derived serum amyloid A (SAA) suppresses anti-tumor immunity in lung cancer by binding to CD36 on antigen-presenting cells (APCs), inhibiting dendritic cell and macrophage activation, promoting M2 polarization, and impairing CD8+ T cell recruitment and function. SAA-neutralizing antibodies effectively reverse this immunosuppression, restoring APC function and enhancing T cell-mediated tumor killing in both in vitro and in vivo models. These findings identify SAA-CD36 signaling as a promising new therapeutic target to overcome immunotherapy resistance in lung cancer.
2025-10-29

August Literature Highlights | Publications Featuring abinScience Products

In August, abinScience facilitated groundbreaking studies published in top journals like Angiogenesis and Redox Biology, advancing research in kidney ischemia/reperfusion injury, skin wound healing, and bacterial morphogenesis. Key findings include the role of eIF5A hypusination in reducing kidney damage, Ang2’s inhibition of wound healing via FGFR2 signaling, and BacA’s regulation of stalk formation in Asticcacaulis biprosthecum. abinScience’s high-purity antibodies and proteins were instrumental in these discoveries, supporting critical experiments in disease research and target identification.

Get a free quote